Model-based analysis and synthesis of tumor growth under angiogenic inhibition: A case study
暂无分享,去创建一个
Levente Kovács | Istvan Harmati | Johanna Sápi | Daniel Andras Drexler | Zoltán Benyó | L. Kovács | Z. Benyó | I. Harmati | D. Drexler | J. Sápi
[1] P. Hahnfeldt,et al. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.
[2] A. Isidori. Nonlinear Control Systems , 1985 .
[3] J. Doyle,et al. Robust and optimal control , 1995, Proceedings of 35th IEEE Conference on Decision and Control.
[4] R. Kerbel. A cancer therapy resistant to resistance , 1997, Nature.
[5] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[6] L. Wein,et al. Optimal scheduling of radiotherapy and angiogenic inhibitors , 2003, Bulletin of mathematical biology.
[7] R. H.,et al. A Medical Dictionary , 1918, Nature.
[8] H. Schättler,et al. A Synthesis of Optimal Controls for a Model of Tumor Growth under Angiogenic Inhibitors , 2005, Proceedings of the 44th IEEE Conference on Decision and Control.
[9] Wai-Chuen Gan. Robust and optimal control of AC machines , 2001 .
[10] J. Folkman,et al. Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.